platinum has been researched along with imatinib mesylate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Butler, LM; Cordeiro, MH; Ebbert, K; Kim, SY; Kurita, T; Mills, AA; Serna, VA; Sinha, S; Woodruff, TK | 1 |
Eskiköy Bayraktepe, D; Yazan, Z; Yıldız, C | 1 |
2 other study(ies) available for platinum and imatinib mesylate
Article | Year |
---|---|
Rescue of platinum-damaged oocytes from programmed cell death through inactivation of the p53 family signaling network.
Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Benzamides; Cells, Cultured; Cisplatin; DNA Damage; Dose-Response Relationship, Drug; Female; Imatinib Mesylate; In Vitro Techniques; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Models, Animal; Nuclear Proteins; Oocytes; Oogenesis; Piperazines; Platinum; Proto-Oncogene Proteins c-abl; Pyrimidines; Signal Transduction; Tumor Suppressor Protein p53 | 2013 |
The development of electrochemical DNA biosensor based on poly-l-methionine and bimetallic AuPt nanoparticles coating: Picomolar detection of Imatinib and Erlotinib.
Topics: Biosensing Techniques; Carbon; DNA; Electrochemical Techniques; Electrodes; Erlotinib Hydrochloride; Gold; Humans; Imatinib Mesylate; Metal Nanoparticles; Platinum | 2023 |